| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Dec 12, 2025 | Dec 12, 2025 | PharmaCyte Biotech, Inc. | Director | Sell | 91.3 | +41,250 | 100.00% | ✗ | $34.4K |
| Oct 17, 2025 | Oct 17, 2025 | TAO Synergies Inc. | CFO | Sell | 91.3 | +6,000 | 56.74% | ✗ | $28.9K |
| Jun 30, 2025 | Jul 2, 2025 | TAO Synergies Inc. | CFO | Sell | 91.3 | +9,246 | 696.23% | ✗ | $48.4K |
| May 30, 2023 | May 31, 2023 | XWELL, Inc. | Director | Buy | 90.0 | +25,000 | 19.01% | ✗ | $6.2K |
| May 26, 2023 | May 30, 2023 | XWELL, Inc. | Director | Buy | 90.0 | +25,000 | 23.48% | ✗ | $6.3K |
| Dec 16, 2022 | Dec 20, 2022 | TAO Synergies Inc. | CFO | Sell | 13.8 | -27,000 | -44.85% | ✓ | $31.6K |
| Apr 20, 2022 | Apr 22, 2022 | XWELL, Inc. | Director | Sell | 13.8 | -45,000 | -29.71% | ✓ | $47.7K |
| Jan 19, 2022 | Jan 21, 2022 | XWELL, Inc. | Director | Sell | 10.0 | -45,000 | -27.23% | ✓ | $70.2K |
| Sep 20, 2021 | Oct 22, 2021 | XWELL, Inc. | Director | Sell | 10.0 | -63,000 | -27.60% | ✓ | $90.2K |